July 15, 2020
According to the research report titled ‘Asia-Pacific In-Vitro Fertilization Market Analysis, 2020’, available with Market Study Report LLC, Asia-Pacific in-vitro fertilization market is predicted to expand with a CAGR of 11.35% between 2020 and 2025.
Increasing number of fertility clinics and rising popularity of surrogacy among women are key factors fostering the demand for in-vitro fertilization in Asia-Pacific. High occurrence of PCOS (polycystic ovarian syndrome) coupled with development of ART (assisted reproductive technology) are further aiding the market expansion.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2767205/
As per cycle type, the market is divided into donor egg IVF cycles, thawed IVF cycles and fresh IVF cycles. The report states that fresh IVF cycles segment held around three-fifth of total market share in the year 2020. Fresh embryo IVF cycle initiates during the ovarian stimulation and is followed by recovery of all eggs from the patient. These eggs are used for producing embryos and then are transferred back, while the remaining eggs are used for future frozen IVF cycles.
In terms of procedure, Asia-Pacific in-vitro fertilization industry is segmented into PGD (pre-implantation genetic diagnosis), FET/FER (frozen embryo transfer/replacement), ICSI (intra cytoplastic sperm injection) and others.
Based on end-user landscape, the industry is categorized into surgical centers, hospitals, clinical research institutes, cryobanks and fertility clinics. The fertility clinics and hospitals segments combinedly held 80% market share in the year 2019 and are expected to register consistent growth throughout the study period. Availability of advanced treatment methods and increasing number of patients in fertility centers are fueling the segmental share. Advancements in healthcare infrastructure and existence of skilled labor in emerging economies such as China and India are also contributing towards popularity of fertility clinics and hospitals for in-vitro fertilization procedures.
By product type, Asia-Pacific in-vitro fertilization industry is bifurcated into devices, reagents, pharmaceuticals and services. The devices segment is further classified into consumables, storage & maintenance systems, sample handling systems, gamete collection & sorting systems and other IVF equipment. On the other hand, the reagents segment is subdivided into gamete processing media, cryopreservation media, embryo culture media and others.
Regionally, Asia-Pacific in-vitro fertilization market is split into Singapore, South Korea, Australia, Japan, India, China and rest of APAC.
The prominent companies operating in Asia-Pacific in-vitro fertilization market are Vitrolife Sweden AB, Olympus Corporation, Thermo Fisher Scientific Inc., Merck KGaA, IVFtech ApS, Ferring Pharmaceuticals, Fujifilm Irvine Scientific, Esco Group of Companies, Cook Medical and Adorefem Gynec & Pro-fertility Division among others.